Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Inventory: 2011-2024

Historic Inventory for Niagen Bioscience (NAGE) over the last 11 years, with Dec 2024 value amounting to $9.2 million.

  • Niagen Bioscience's Inventory rose 78.22% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 78.22%. This contributed to the annual value of $9.2 million for FY2024, which is 36.72% down from last year.
  • Per Niagen Bioscience's latest filing, its Inventory stood at $9.2 million for FY2024, which was down 36.72% from $14.5 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Inventory registered a high of $14.7 million during FY2022, and its lowest value of $9.2 million during FY2024.
  • Moreover, its 3-year median value for Inventory was $14.5 million (2023), whereas its average is $12.8 million.
  • As far as peak fluctuations go, Niagen Bioscience's Inventory climbed by 16.42% in 2021, and later crashed by 36.72% in 2024.
  • Over the past 5 years, Niagen Bioscience's Inventory (Yearly) stood at $11.7 million in 2020, then rose by 16.42% to $13.6 million in 2021, then grew by 7.91% to $14.7 million in 2022, then dropped by 1.04% to $14.5 million in 2023, then slumped by 36.72% to $9.2 million in 2024.